Drug-associated valvular heart diseases and serotonin-related pathways: a meta-analysis.

Jacqueline H FortierBeatrice PizzarottiRichard E ShawRobert J LevyGiovanni FerrariJuan B Grau

Published in: Heart (British Cardiac Society) (2019)

There was a consistent, significant association between many medications that affect serotonergic pathways and valvular heart disease. Although many of these medications have been withdrawn from the market, some small studies suggest that recreational drug 3,4-methylenedioxymethamphetamine and widely prescribed selective serotonin reuptake inhibitors may affect similar pathways.

Keyphrases

atrial fibrillation
heart failure
aortic valve
pulmonary hypertension
drug induced
health insurance
adverse drug